Drug Database · Clinicians

Ofloxacin

Brands (41) Inoflox, Qinolon, Dizoflox…Show all

US brand (reference label): OCUFLOX; not a Philippine-registered brand.

Quinolone Antimicrobial US FDA class
Antibacterial (fluoroquinolone); Antibacterial (quinolone); and others PH FDA category

Rx · Prescription drug56 PH productsPNF-listed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 7aab4449-3dda-4e2c-8e40-b3244a548bf5, version date June 13, 2024 (OCUFLOX · Allergan, Inc.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • INDICATIONS AND USAGE OCUFLOX ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: CONJUNCTIVITIS: Gram-positive…
US FDA label
Full indications and usage US FDA label

INDICATIONS AND USAGE OCUFLOX ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: CONJUNCTIVITIS: Gram-positive bacteria: Gram-negative bacteria: Staphylococcus aureus Enterobacter cloacae Staphylococcus epidermidis Haemophilus influenzae Streptococcus pneumoniae Proteus mirabilis Pseudomonas aeruginosa CORNEAL ULCERS: Gram-positive bacteria: Gram-negative bacteria: Staphylococcus aureus Pseudomonas aeruginosa Staphylococcus epidermidis Serratia marcescens* Streptococcus pneumoniae Anaerobic species: Propionibacterium acnes *Efficacy for this organism was studied in fewer than 10 infections

Contraindications

CONTRAINDICATIONS OCUFLOX ® solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication (s ee Warnings).

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label

DOSAGE AND ADMINISTRATION The recommended dosage regimen for the treatment of bacterial conjunctivitis is: Days 1 and 2 Instill one to two drops every two to four hours in the affected eye(s). Days 3 through 7 Instill one to two drops four times daily. The recommended dosage regimen for the treatment of bacterial corneal ulcer is: Days 1 and 2 Instill one to two drops into the affected eye every 30 minutes, while awake.

Awaken at approximately four and six hours after retiring and instill one to two drops. Days 3 through 7 to 9 Instill one to two drops hourly, while awake. Days 7 to 9 through treatment completion Instill one to two drops, four times daily.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosing: Pediatric

Pediatric use (US label) US FDA label

Pediatric Use Safety and effectiveness in infants below the age of one year have not been established. Quinolones, including ofloxacin, have been shown to cause arthropathy in immature animals after oral administration; however, topical ocular administration of ofloxacin to immature animals has not shown any arthropathy. There is no evidence that the ophthalmic dosage form of ofloxacin has any effect on weight bearing joints.

Dosing: Older adult

Geriatric use (US label) US FDA label

Geriatric Use No overall differences in safety or effectiveness have been observed between elderly and younger patients.

Dosage forms

Philippines

  • Ophthalmic solution: 3 mg/mL
  • Otic solution: 3 mg/mL
  • Tablet: 200 mg, 400 mg
  • Film-coated tablet: 200 mg, 400 mg
  • ) solution for i.v. infusion: 2 mg/mL (200 mg/100 mL, 200 MG/100 ML (2 MG/ML
  • ) solution for intravenous infusion: 2 mg/mL (200 mg/100 mL
  • ) solution for iv infusion: 2 mg/mL (200 mg/100 mL, 200 mg/100 mL (2 mg/mL
  • Capsule: 200 mg
  • ) solution for infusion: 200 mg/100 mL (2 mg/mL
  • Eye drops solution: 3 mg/mL

and 6 more forms; see the products table.

Registered products in the Philippines

56 products registered with the Food and Drug Administration (FDA) Philippines list Ofloxacin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products56
Philippine FDA-registered products for Ofloxacin
Package insert
AflacinOfloxacin
3 mg/mL (0.3% w/v) Sterile Ophthalmic Solution (Eye Drops)Sterile LDPE dropper tip bottle x 5 mL (Box of 1's)
Rx
Laboratorios Ashford Lda.China
Marrion Pharma Inc.
DRP-6033
Feb 15, 2037
Agua OfioOfloxacin
3 mg/mL (0.3% w/w) Ophthalmic SolutionOpaque Plastic Bottle x 5mL and 10 mL (Box of 1's)
Rx
Indiana OphthalmicsIndia
Agua Visions TradingImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-4998-01
Sep 7, 2027
AkuofloOfloxacin
2 mg/mL Solution for I.V. InfusionLDPE Plastic Bottle with White Plastic Cap x 100 mL (Box of 1’s)
Rx
Akums Drugs & Pharmaceuticals Ltd. (Plant III – Injectables)India
Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-4291
Mar 8, 2037
DizofloxOfloxacin
3 mg/mL (0.3%) Ophthalmic Solution (Eye Drops)5 mL in 10mL E/D Plastic filled with a whole plastic dropper plug with white plastic tamper proof cap (Box of 1's)
Rx
Ashford Pharamceutical Laboratories, Inc.Philippines
Trader: Vendiz Pharmaceuticals, Inc.
DRP-10387
Jan 6, 2031
DizofloxOfloxacin
3 mg/mL (0.3%) Otic Solution10 mL LDPE Plastic Bottle 5 mL content and 2.5 mL Physician Sample (Box of 1's)
Rx
Ashford Pharmaceutical Laboratories, Inc.Philippines
Trader: Vendiz Pharmaceuticals Inc.
DRP-10526
Feb 18, 2029
ElifloxOfloxacin
200mg CapsuleFoil Strip x 10's Box of 100's
Rx
Drugmaker's Laboratories, Inc.Philippines
—
DRP-5602
May 26, 2027
FamoxaOfloxacin
200mg / 100mL (2mg / mL) Solution for IV InfusionPolypropylene (PP) Bottle x 100 mL (Box of 1's)
Rx
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Importer: AMB HK Enterprises Inc.
DRP-11321
Feb 28, 2032
FloaxaOfloxacin
3mg/mL (0.3%w/v) Ophthalmic Solution10 mL LDPE vial with spike cap (Box of 1's)
Rx
Axa Parenterals LimitedIndia
Brady Pharma Inc.
DRP-11946
May 23, 2027
FloxOfloxacin
2 mg/mL (200 mg/100 mL) Solution for I.V. InfusionLDPE bottle x 100 mL (Box of 1's)
Rx
Amanta Healthcare Ltd.India
Endure Medical, Inc.
DR-XY36667
Sep 17, 2029
Floxa-200Ofloxacin
200 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Centurion Remedies Pvt. Ltd.India
Importer: Philgen Pharmaceuticals Inc.
DRP-2505
Oct 8, 2030
Floxa-400Ofloxacin
400 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Centurion Remedies Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-2506
Oct 8, 2030
FloxacincareOfloxacin
3 mg / mL (0.3% w/w) Ophthalmic SolutionOpaque Plastic Bottle x 5mL and 10 mL (Box of 1's)
Rx
Indiana OphthalmicsIndia
Sensorycare Pharma Co.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-4998-02
Sep 7, 2027
FloxagenOfloxacin
200 mg TabletAluminum Foil Strip x 10's (Box of 100's)
Rx
Sydenham Laboratories, Inc.Philippines
Trader: Vonnace Pharmaceuticals Corporation
DR-XY20695-B
May 30, 2027
FloxopOfloxacin
0.3% w/v Ophthalmic Solution5 mL Sterile Solution Filled in 5 mL Milky White LDPE Vial (Box of 1's)
Rx
East African (India) OverseasIndia
Airlife International Trading Corp.
DRP-17899
Apr 7, 2031
Floxy-200Ofloxacin
200 mg TabletFoil Strip x 10's (Box of 100's)
Rx
Millimed Co., LTD.Thailand
MG Prime Pharmaceutical, Inc.Importer: Atlantic Pharmaceuticals Inc.
DRP-2589
Aug 25, 2031
FluraxidOfloxacin
200 mg Film-Coated TabletFoil Strip x 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Eadriex Pharmaceuticals, Phils., Inc.
DR-XY30380
Dec 10, 2029
FluraxidOfloxacin
400 mg Film-Coated TabletFoil Strip x 10's Box of 50's
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Eadriex Pharmaceuticals, Phils., Inc.
DR-XY30379
Dec 10, 2029
FolaxinOfloxacin
200 mg Film-Coated TabletFoil Strip x 10's Box of 100's
Rx
Lloyd Laboratories, Inc.Philippines
Medirich Pharma Distribution Corp.Trader: Euro-Health Care Exponents, Inc.
DRP-6835-01
Jan 13, 2030
IblesOfloxacin
3 mg/mL (0.3% w/v) Ophthalmic SolutionOpaque White Plastic Dropper Container with Nozzle and Cap x 5 mL (Box of 1's)
Rx
Makcur Laboratories LimitedIndia
Importer: Afree Pharmaceutical Distribution Corp.
DRP-12653
Sep 19, 2027
InofloxOfloxacin
200 mg TabletAluminum Flex Foil x 6's (Box of 30's); Aluminum Flex Foil x 4's (Box of 100's)
Rx
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY7575
May 24, 2031
InofloxOfloxacin (as hydrochloride)
200 mg/100 mL Solution for Infusion (IV)100 mL Clear and colorless glass vial with rubber stopper and green flip-off seal (Box of 1's)
Rx
Amherst Parenterals, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY28272
Jan 30, 2028
InofloxOfloxacin
3 mg/mL Otic SolutionSqueezable Plastic Container x 5 mL (Box of 1's)
Rx
Santen Pharmaceuticals Co., Ltd. (Noto Plant)Japan
UNILAB, Inc.
DR-XY21447
Jun 7, 2027
InofloxOfloxacin
400 mg TabletAluminum Flex Foil x 10's (Box of 30's); Aluminum Flex Foil x 4's (Box of 100's)
Rx
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY18641
May 24, 2031
LofectionOfloxacin
400 mg TabletBlister Pack x 6's in individual box (Box of 60's)
Rx
Unichem Laboratories LimitedIndia
Ambica International Corporation
DRP-6464
Jul 15, 2032
NoneOfloxacin
200mg CapsuleFoil Strip x 10's Box of 100's
Rx
Drugmaker's Laboratories, Inc.Philippines
TGP Pharma Inc.
DRP-5602-01
May 26, 2027
NoneOfloxacin
3 mg/mL (0.3% w/v) Ophthalmic SolutionPlastic squeeze bottle x 5 mL (Box of 1's)
Rx
Ashford Pharmaceutical Laboratories, Inc.Philippines
Celsus Pharmaceuticals Phils., Inc.Trader: Pharmabiz Solutions, Inc.
DRP-2449-01
Mar 16, 2031
NoneOfloxacin
3 mg/mL (0.3% w/v) Otic SolutionPlastic Bottle x 5 mL (Box of 1's)
Rx
Ashford Pharmaceutical Laboratories, Inc.Philippines
Celsus Pharmaceuticals Phils., Inc.Trader: Pharmabiz Solutions, Inc.
DRP-2448-01
Mar 6, 2031
OcinOfloxacin
3 mg/mL (0.3% w/v) Eye Drops SolutionLow Density Polyethylene (LDPE) FFS Container x 5 mL
Rx
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DR-XY36568
Aug 27, 2031
OfiyanaOfloxacin
3 mg/mL (0.3% w/v) Ophthalmic Solution10 mL opaque plastic bottle with white opaque LDPE nozzle and white opaque HDPE cap (Box of 1's)
Rx
Indiana OphthalmicsIndia
Aglobal Care, Inc.
DRP-13691
Apr 13, 2028
OflazOfloxacin
3 mg / mL (0.3% w/v) Ophthalmic Solution15 mL White LDPE Bottle Sealed with Cap x 10 mL (Net content) (Box of 1’s)
Rx
Skymap Healthcare Pvt. Ltd.India
Ophtha Pharma Traders Inc.Importer: AMB HK Enterprises, Inc.
DRP-11588-02
Mar 30, 2027
OflobizOfloxacin
3 mg/mL (0.3% w/v) Ophthalmic SolutionPlastic Squeeze Bottle x 5 mL Box of 1's
Rx
ASHFORD PHARMACEUTICAL LABORATORIES, INC.Philippines
Trader: PHARMABIZ SOLUTIONS, INC.
DRP-2449
Feb 15, 2037
OflobizOfloxacin
3 mg/mL (0.3% w/v) Otic SolutionPlastic bottle x 5 mL Box of 1's
Rx
Ashford Pharmaceutical Laboratories, Inc.Philippines
Trader: Pharmabiz Solutions, Inc.
DRP-2448
Feb 9, 2037
OFLOLIFEOFLOXACIN
200 MG/ 100 ML (2 MG/ML) Solution For I.V. InfusionLDPE Blow Molded Bottle x 100 mL (Box of 1's)
Rx
Eurolife Healthcare Pvt. Ltd.India
Aglobal Care, Inc.
DRP-7922
Nov 8, 2031
OflomaxOfloxacin
2mg/mL (200mg/100mL) Solution for IV InfusionType I Clear Glass Bottle x 100mL (Box of 1's)
Rx
Lu'an Worldbest Pharmaceutical Co., Ltd.China
Global Pharmatrade
DR-XY41410
Nov 13, 2027
OflotechOfloxacin
2 mg/mL (0.2 % w/v) Solution for IV Infusion100 mL LDPE Plastic Bottle (Box of 1’s)
Rx
Akums Drugs & Pharmaceuticals Ltd.India
Ambica International CorporationTrader: Unosource Pharma Ltd.
DRP-3939
Sep 5, 2030
Ofloxasaph-INFOfloxacin
2 mg/mL (200 mg/100 mL) Solution for Intravenous Infusion100 mL LDPE bottle with white protective cap (Box of 1's)
Rx
Althea Pharma Pvt. Ltd.India
Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt., Ltd.
DRP-15072
Apr 12, 2029
Ofloxasaph-INFOfloxacin
3 mg/mL (0.3% w/v) Ophthalmic Solution (Eye Drops)5 mL white HDPE dropper bottle with plastic nozzle and plastic cap (Box of 1's)
Rx
Kilitch Drugs (India) Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-14880
Jan 31, 2029
Ofloxasaph-OtOfloxacin
2 mg/mL (200 mg/100 mL) Solution For I.V. InfusionWhite colored LDPE Bottle x 100 mL (Box of 1's)
Rx
Althea Pharma Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-13320
Jan 26, 2028
OfloxasaveOfloxacin
3 mg/mL Ophthalmic Solution (Eye Drops)White HDPE Plastic Bottle x 5 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Savelink Pharma and Trading Co.Importer: Accesspoint International Trading Inc.
DRP-13789-01
Apr 20, 2028
OfloxenOfloxacin
3 mg/g (0.3% w/w) Ophthalmic Ointment2 g Aluminum Collapsible Tube (Box of 1's)
Rx
Cisen Pharmaceutical Co., LtdChina
Endure Medical Inc.
DR-XY43502
Jun 25, 2029
OframacOfloxacin
200 mg Film-Coated TabletFoil Strip x 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Euro-Health Care Exponents, Inc.
DRP-6835
Jan 13, 2030
OframacOfloxacin
400 mg Film-Coated TabletStrip Foil x 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Euro-Health Care Exponents, Inc.
DRP-9421
Jan 18, 2031
OleOfloxacin
3 mg/mL (0.3% w/w) Ophthalmic SolutionOpaque Plastic Bottle x 5mL and 10 mL (Box of 1's)
Rx
Indiana OphthalmicsIndia
Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-4998
Sep 7, 2027
OmefloxOfloxacin
3 mg/mL (0.3% w/v) Otic SolutionLDPE Bottle x 5 mL (Box of 1's)
Rx
Makcur Laboratories LimitedIndia
Ensight Pharmaceuticals Inc.Trader: Entod Pharmaceuticals Ltd.
DR-XY49759
Jul 6, 2031
OplaseOfloxacin
3mg/mL (0.3% w/v) Ophthalmic Solution15 mL White LDPE Bottle Sealed with Cap x 10 mL (Net content) (Box of 1's)
Rx
Skymap Healthcare Pvt. Ltd.India
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-11588
Mar 30, 2027
OplaseOfloxacin
3mg/mL (0.3% w/v) Ophthalmic Solution15 mL White LDPE Bottle Sealed with Cap x 10 mL (Net content) (Box of 1's)
Rx
Skymap Healthcare Pvt. Ltd.India
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-11839
May 6, 2027
OptiquinOfloxacin
3 mg/mL Ophthalmic Solution (Eye Drops)White HDPE Plastic Bottle x 5 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) Limited.Pakistan
Accesspoint International Trading, Inc.
DRP-13789
Apr 20, 2028
OtofloxOfloxacin
3 mg/mL (0.3% w/v) Otic Solution (Drops)HDPE Plastic Bottle x 7.5 mL (Box of 1's)
Rx
Ashford Pharmaceutical Laboratories, Inc.Philippines
Trader: Sensomed Phils., Inc.
DR-XY32631
Nov 17, 2031
OttofloxOfloxacin
3 mg/mL Otic SolutionIn opaque white LDPE bottle with transparent dropper insert and opaque white HDPE cap with tamper-proof closure x 10 mL (Box of 1's)
Rx
Laboratorio Edol - Produtos Farmaceuticos, S.A.Portugal
Ambicare Pharmaceuticals Inc.
DRP-9349
Feb 9, 2037
QinolonOfloxacin
200 mg TabletFoil Strip Pack x 4's Box of 100's
Rx
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, INC.
DR-XY7167
May 25, 2027
QinolonOfloxacin (as hydrochloride)
200 mg/100 mL (2 mg/mL) Solution for Infusion (IV)100 mL Clear glass vial with rubber stopper and green flip-off seal (Box of 1's)
Rx
Amherst Parenterals, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY28270
Jan 30, 2028
QinolonOfloxacin
400 mg TabletAluminum Flex Foil x 4's (Box of 100's)
Rx
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY18554
Aug 2, 2027
QuinoCareOfloxacin
3 mg/mL (0.3% w/v) Otic SolutionPlastic bottle x 5 mL (Box of 1's)
Rx
Ashford Pharmaceutical Laboratories, Inc.Rizal
Sensorycare Pharma Co.Trader: Pharmabiz Solutions, Inc.
DRP-2448-02
May 14, 2030
SiofloxOfloxacin
2 mg/mL (200 mg/ 100 mL) Solution for Intravenous Infusion100 mL in white transparent Low Density Polyethylene (LDPE) bottle with euro-head plastic cap (Box of 1's)
Rx
Albert David LimitedIndia
Medethix, Inc.
DRP-6905
Nov 3, 2029
UnbrandedOfloxacin
400 mg TabletFoil Strip x 10's (Box of 100's)
Rx
Pascual Laboratories, Inc.Bulacan
Pharex Health Corporation
DRP-5937
Dec 6, 2031
ZOOFLOXACIN
3 mg/mL (0.3% w/v) Ophthalmic SolutionLow Density Polyethylene (LDPE) Plastic Vial x 5 mL Box of 1's
Rx
FDC LIMITEDIndia
PENTA LABS AUSTRALIA (PHILIPPINES)
DRP-5570
Dec 5, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

WARNINGS NOT FOR INJECTION. OCUFLOX ® solution should not be injected subconjunctivally, nor should it be introduced directly into the anterior chamber of the eye. There are rare reports of anaphylactic reaction/shock and fatal hypersensitivity reactions in patients receiving systemic quinolones, some following the first dose, including ofloxacin.

Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dyspnea, urticaria, and itching. A rare occurrence of Stevens-Johnson syndrome, which progressed to toxic epidermal necrolysis, has been reported in a patient who was receiving topical ophthalmic ofloxacin.

If an allergic reaction to ofloxacin occurs, discontinue the drug. Serious acute hypersensitivity reactions may require immediate emergency treatment. Oxygen and airway management, including intubation should be administered as clinically indicated.

Drug interactions

Drug interactions (US label) US FDA label

Drug Interactions Specific drug interaction studies have not been conducted with OCUFLOX ® ophthalmic solution. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.

Adverse reactions

Adverse reactions (US label) US FDA label

ADVERSE REACTIONS Ophthalmic Use The most frequently reported drug-related adverse reaction was transient ocular burning or discomfort. Other reported reactions include stinging, redness, itching, chemical conjunctivitis/keratitis, ocular/periocular/facial edema, foreign body sensation, photophobia, blurred vision, tearing, dryness, and eye pain. Rare reports of dizziness and nausea have been received. Refer to Warnings for additional adverse reactions.

Pregnancy considerations

Pregnancy (US label) US FDA label

Pregnancy Teratogenic Effects Ofloxacin has been shown to have an embryocidal effect in rats and in rabbits when given in doses of 810 mg/kg/day (equivalent to 9000 times the maximum recommended daily ophthalmic dose) and 160 mg/kg/day (equivalent to 1800 times the maximum recommended daily ophthalmic dose). These dosages resulted in decreased fetal body weight and increased fetal mortality in rats and rabbits, respectively.

Minor fetal skeletal variations were reported in rats receiving doses of 810 mg/kg/day. Ofloxacin has not been shown to be teratogenic at doses as high as 810 mg/kg/day and 160 mg/kg/day when administered to pregnant rats and rabbits, respectively.

Breastfeeding considerations

Lactation (US label) US FDA label

Nursing Mothers In nursing women a single 200 mg oral dose resulted in concentrations of ofloxacin in milk which were similar to those found in plasma. It is not known whether ofloxacin is excreted in human milk following topical ophthalmic administration. Because of the potential for serious adverse reactions from ofloxacin in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Pharmacokinetics

Half-life and elimination (verbatim, US label)

Ofloxacin was excreted in the urine primarily unmodified.

Pharmacokinetics (US label) US FDA label

Pharmacokinetics Serum, urine and tear concentrations of ofloxacin were measured in 30 healthy women at various time points during a ten-day course of treatment with OCUFLOX ® solution. The mean serum ofloxacin concentration ranged from 0.4 ng/mL to 1.9 ng/mL. Maximum ofloxacin concentration increased from 1.1 ng/mL on day one to 1.9 ng/mL on day 11 after QID dosing for 10 1/2 days.

Maximum serum ofloxacin concentrations after ten days of topical ophthalmic dosing were more than 1000 times lower than those reported after standard oral doses of ofloxacin. Tear ofloxacin concentrations ranged from 5.7 to 31 mcg/g during the 40 minute period following the last dose on day 11. Mean tear concentration measured four hours after topical ophthalmic dosing was 9.2 mcg/g.

Corneal tissue concentrations of 4.4 mcg/mL were observed four hours after beginning topical ocular application of two drops of OCUFLOX ® ophthalmic solution every 30 minutes. Ofloxacin was excreted in the urine primarily unmodified.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Ofloxacin Ear Drops 0.3%, 5 mL Bottle₱175.00–₱250.00Reference ₱200.00per bottleDPRI procurement range
Ofloxacin Eye Drops 0.3%, 5 mL Bottle₱167.00–₱170.00Reference ₱167.00per bottleDPRI procurement range
Ofloxacin 200 mg Tablet₱1.78–₱4.85Reference ₱3.75per tabletDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Ofloxacin
PNF listingOral: 200 mg tablet
PNF listingEye Drops Solution: 0.3%, 5 mL bottle
PNF listingEar Drops Solution: 0.3%, 5 mL bottle
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. OCUFLOX · Allergan, Inc. [US FDA-approved label, version 13, June 13, 2024]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7aab4449-3dda-4e2c-8e40-b3244a548bf5
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .